SPE Capital, an investment company with a focus on Africa and the Middle East, announces the acquisition of a majority stake in Vital, the top manufacturer of dietary supplements in Tunisia, by its private equity fund SPE AIF I. The fund’s fourth investment in 2022 and its ninth overall is Vital.
Since its founding in 2000, Vital has developed into Tunisia’s top manufacturer of herbal medicines and dietary supplements, producing 8 million units annually and offering a portfolio of over 400 premium brand products that are sold both domestically and abroad.
On the strength of ongoing new product development and consistent organic growth, the company has increased to 400 employees and established itself as the market leader for nutritional supplements in Tunisia.
The expenditure in Vital includes a primary capital investment to further scale up the company’s product portfolio, boost its sales & marketing and drive its international expansion over the coming years.